FORMAZIONE E RELAZIONI A CONGRESSI
Laureato in Medicina e Chirurgia presso l’Università di Roma Tor Vergata con 110/110 e lode, ho successivamente conseguito la specializzazione in Dermatologia e Venereologia presso l’Università Cattolica del Sacro Cuore di Roma (Policlinico Agostino Gemelli - Roma) con il massimo dei voti.
Ho partecipato in qualità di relatore a numerosi congressi nazionali ed internazionali, con un focus in particolare su psoriasi e malattie infiammatorie cutanee
ISCRIZIONI
Membro dell’European Academy of Dermatology and Venereology (EADV)
Membro della Società Italiana di Dermatologia e Malattie Sessualmente Trasmesse (SIDeMaST)
PUBBLICAZIONI SCIENTIFICHE
Torres T, Puig L, Vender R, Yeung J, Carrascosa JM, Piaserico S, Gisondi P, Lynde C, Ferreira P, Bastos PM, Dauden E, Leite L, Valerio J, Del Alcázar-Viladomiu E, Rull EV, Llamas-Velasco M, Pirro F, Messina F, Bruni M, Licata G, Ricceri F, Nidegger A, Hugo J, Mufti A, Daponte AI, Teixeira L, Balato A, Romanelli M, Prignano F, Gkalpakiotis S, Conrad C, Lazaridou E, Rompoti N, Papoutsaki M, Nogueira M, Chiricozzi A. Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study. Am J Clin Dermatol. 2022 Aug 17. doi: 10.1007/s40257-022-00722-y
Pellacani G, Bigi L, Parodi A, Burlando M, Lanna C, Campione E, Rongioletti F, Mugheddu C, Malara G, Moretti G, Stingeni L, Hansel K, Micali G, Naldi L, Pirro F, Peris K. Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study. J Clin Med. 2022 Aug 16;11(16):4778. doi: 10.3390/jcm11164778.
De Simone C, Fargnoli MC, Amerio P, Bianchi L, Esposito M, Pirro F, Potenza C, Ricceri F, Rongioletti F, Stingeni L, Prignano F. Risk of infections in psoriasis: assessment and challenges in daily management. Expert Rev Clin Immunol. 2021 Nov;17(11):1211-1220. doi: 10.1080/1744666X.2021.1997592
Pirro F, Caldarola G, Chiricozzi A, Burlando M, Mariani M, Parodi A, Peris K, De Simone C. Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study. Clin Drug Investig. 2021 Oct;41(10):917-925. doi: 10.1007/s40261-021-01080-z.
M Galluzzo, G Caldarola, C De Simone, N Bernardini, G Moretta, S Pallotta, E Botti, E Campione, F Pirro, C. Potenza , L Bianchi, e K Peris. Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy. Expert Opinion on Biological Therapy 2021, VOL. 21, NO. 9, 1299-1310. doi: 10.1080/14712598.2021.1941862
Zangrilli A, Caldarola G, Bernardini N, Bavetta M, Graceffa D, Bonifati C, Cantoresi F, Faleri S, Giordano D, Mariani M, Micheli A, Moretta G, Pirro F, Pagnanelli G, Panasiti V, Provini A, Richetta A, Sacchelli L, Bianchi L, Peris K. Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy. Expert Opin Biol Ther. 2021 Sep;21(9):1291-1298. doi: 10.1080/14712598.2021.1948530.
Esposito Maria, Giunta Alessandro, Gisondi Paolo, Tambone Sara, Rovaris Marco, Manfreda Valeria, Pirro Federico, Pellegrini Cristina, Fargnoli Maria Concetta, Bianchi Luca, Peris Ketty, Girolomoni Giampiero. Satisfaction and attitudes toward systemic treatments for psoriasis: a cross-sectional study. Dermatol Ther. 2021 Mar 16:e14949. doi: 10.1111/dth.14949
Giacomo Caldarola, Marco Mariani, Federico Pirro, Nicola Nicolotti, Martina Burlando, Laura Calabrese, Aurora Parodi, Ketty Peris & Clara De Simone. Comparison of Short and Long-term Effectiveness of Ixekizumab and Secukinumab in Real-World Practice. Expert Opinion on Biological Therapy 2020. doi: 10.1080/14712598.2021.1849133
Pirro Federico, Caldarola Giacomo, Chiricozzi Andrea, et al. The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies. J Dermatolog Treat. 2020;1-14. doi:10.1080/09546634.2020.1800578
D'Urso Dario Francesco, Chiricozzi Andrea, Pirro Federico, Calabrese Laura, Caldarola Giacomo, Fossati Barbara, De Simone Clara, Peris Ketty. New jak inhibitors for the treatment of psoriasis and psoriatic arthritis. G Ital Dermatol Venereol. 2020. doi: 10.23736/S0392-0488.20.06658-4
Caldarola Giacomo, Pirro Federico, Di Stefani Alessandro, Talamonti Marina, Galluzzo Marco, D’Adamio Simone, Magnano Michela, Bernardini Nicoletta, Malagoli Piergiorgio, Bardazzi Federico, Potenza Concetta, Bianchi Luca, Peris Ketty & De Simone Clara. Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature, Expert Opinion on Biological Therapy, Feb 2020 doi: 10.1080/14712598.2020.1727439
De Simone Clara, Caldarola Giacomo, Pirro Federico, Calabrese Laura. Adalimumab biosimilare nella psoriasi: esperienza clinica nei pazienti naive e post-switch da altre molecole. Intern Emerg Med (2019) NS1: NS4-NS6
Gori Niccolò, Caldarola Giacomo, Pirro Federico, De Simone Clara, Peris Ketty. A case of guttate psoriasis during treatment with dupilumab. Dermatol Ther. 2019 Jun 19:e12998. doi: 10.1111/dth.12998.
Pirro Federico, Caldarola Giacomo, De Simone Clara, Moretta Gaia, Giovanardi Giulia, Peris Ketty. Multiple paradoxical reactions during ixekizumab therapy. Dermatol Ther. 2019 Feb 12:e12852. doi: 10.1111/dth.12852